EU regulator backs approval for GSK injectable asthma drug – Reuters


Reuters

EU regulator backs approval for GSK injectable asthma drug
Reuters
GlaxoSmithKline Plc said the European health regulator had recommended an approval for its injectable drug to treat asthma patients who don't respond well to traditional inhalers. The European Commission is expected to decide on a final approval for
Glaxo asthma drug clears key hurdle in EuropeMarketWatch
GlaxoSmithKline's asthma injection heads for EU approvalFierceBiotech
Europe's CHMP give thumbs up to Glaxo's Nucala for severe asthmaSeeking Alpha

all 12 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.